I. Glomerulonephritis.- Modulation of endothelial barrier and coagulant properties by hypoxia.- Cellular immunity in glomerular pathology primarily induced by immune-complexes.- Immunosuppressive treatment of autoimmune nephropathies.- Effect of proteinase inhibitor Camostat Mesilate on nephrotic syndrome.- Treatment of nephrotic hyperlipidemia.- Effect of PSK administration followed by initial prednisolone therapy in the steroid responsive idiopathic nephrotic children.- Zinc therapy for minimal change nephrotic syndrome and its effect on IgG synthesis.- The nephrotic syndrome in the elderly: epidemiological data.- Antiaggregating platelet therapy in chronic glomerulonephritis (GN).- Membranoproliferative glomerulonephritis type I: a correlation between treated (138) and untreated (108) patients.- Methylprednisolone (MP) pulse therapy in childhood IgA nephropathy.- Immunosuppressive treatment of Berger's disease.- High dose intravenous human IgG in the treatment of idiopathic membranous nephropathy: preliminary report of a multicentric trial.- Treatment of patients with membranous nephropathy (MN).- Anticoagulant therapy and steroid pulse therapy to rapidly progressive IgA nephropathy.- Contemporary treatment of idiopathic membranous glomerulonephritis.- Effect of methylprednisolone pulse therapy in patients with Lupus Nephritis assessed by WHO morphologic classification.- Effect of Dilazep dihydrochloride (DZ) therapy in patients with chronic glomerulonephritis.- Follow-up of treated patients with primitive membranous nephritis.- Role of ACE inhibition in IgA nephropathy.- Early indicators of renal disease in parenteral substance abusers.- Platelet derived growth factor and interleukin-1 expression are increased in murine IgA nephropathy.- Effect of cyclosporine A on the anionic sites in the glomerular basement membrane of Puromycin nephrotic rats.- Therapeutic approach for the deteriorated renal function in IgA nephropathy.- IgA nephropathy and cytomegalovirus.- Intestinal permeability and antibodies against dietary antigens in IgA nephropathy.- Parameters affecting the poor prognosis of IgA nephropathy -a clinical study.- Successful induction of seroconversion and diminished proteinuria in 3 cases of hepatitis B virus (HBV) associated glomerulonephritis.- Goodpasture's syndrome: a clinical case.- Effects of Piretanide on renal function and the ANP/RAA-system in patients with the nephrotic syndrome.- Inhibition of the hydroxyl radical by dimethylthiourea and proteinuria in adriamycin experimental nephrosis.- Late treatment with Captopril worsens the course of Adriamycin nephropathy in rats.- II. Acute Renal Failure.- Acute renal failure after poisoning with concentrated acetic acid.- Daily recycled bicarbonate dialysis in treatment for acute renal failure in critically ill patients.- Endotoxin stimulates synthesis of platelet activating factor via production of tumor necrosis factor by human mesangial cells.- Reversible acute renal failure in Lupus Nephritis due to a hypertensive crisis.- Early effects of acute obstruction of biliary duct in the rat.- III. Chronic Renal Failure.- Treatment of hypertension in chronic renal failure. p.- Geographical distribution of the unknown aetiology end-stage renal failure in Greece.- Valuation of the immunological parameters in chronic renal insufficient patients with or without haemodialytic treatment.- Chronic renal failure (CRF) and lipidemic parameters.- The effect of cimetidine on parathyroid in the uremic patients.- Bone GLA protein in chronic renal failure.- Cystic diseases in uremia and HLA system.- Cardiac morphology evaluation in patients with chronic renal failure: an echocardiographic study.- ANP in chronic renal failure is related to plasma creatinine but not to blood pressure or dialysis.- Correlation of biochemical and histological indices of renal osteodystrophy in patients with mild to moderate chronic renal failure.- Does Indomethacin in Bartter's syndrome interfere
The successful series of International Meetings on "Current Therapy in Nephrology" (now known around the world as "Sorrento Meeting") has continued this year with the third meeting of the series, updating on new therapeutic strategies in Nephrology. This time the meeting was held at the Cocumella Hotel of Sorrento, Italy, on May 27-30, 1990, in a wonderful atmosphere, with the participation of outstanding scientists, such as Drs. H. Auchincloss (Boston, USA), E. Bartoli (Udine, Italy), V. Bonomini (Bologna, Italy), M. Broyer (Paris, France), V. Cambi (Parma, Italy), G. Camussi (Naples, Italy), J.M. Dubemard (Lyon, France), G. Haycock (London, U.K.), G. Jacobs (Paris, France), C. Kjellstrand (Minneapolis, USA), R. Maiorca (Brescia, Italy), G. Maschio (Verona, Italy). As many as five hundred nephrologists from all over the world (European Countries, Israel, U.S.A., Taiwan, Corea, Japan) attended the meeting, actively participating in the discussion of a great number of good papers and posters. Important lectures by invited speakers have dealed with mediators of inflammation, cellular immunity in glomerular pathology, immunosuppressive therapy in autoimmune nephropathies, treatment of hypertension in chronic renal failure, dialysis compatibility, xenogenic transplantation. Very interesting controversies have been included in the programme: "Extracorporeal or peritoneal dialysis for uremic children?" (M. Broyer against G. Haycock) and "Extracorporeal or peritoneal dialysis for diabetic uremic patients?" (c. Kjellstrand against C. Jacobs). Their presentation has been quite successful with a great participation in the discussion by Congress members.
Springer Book Archives